Historical record - last NADAC effective date: 11/19/2014
Product Information
CORICIDIN HBP SOFTGEL is a brand product labeled by Bayer HealthCare LLC, priced at $0.2267 per EA under NDC 11523715802. Its NADAC has been published 33 times since May 21, 2014.
Strength
10; 200 mg/1; mg/1
Manufacturer
Bayer HealthCare LLCNDC
11523715802
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
11/19/2014
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/31/2000
Pharmacological Classes
Price Statistics
The NADAC for CORICIDIN HBP SOFTGEL has been published 33 times since May 21, 2014, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2267 per EA |
|---|---|
| All-time high | $0.2267 (Dec 31, 2014) |
| All-time low | $0.2142 (Jun 18, 2014) |
| Median price | $0.2142 |
| Average price | $0.2185 |
| Largest weekly change | +4.9% (Oct 22, 2014) |
| Weeks tracked | 33 |
| Tracking since | May 21, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+4.4%
Last surveyed Dec 31, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan hydrobromide and Guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bayer HealthCare LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan hydrobromide and Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CORICIDIN HBP SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for CORICIDIN HBP SOFTGEL, manufactured by Bayer HealthCare LLC, is $0.2267 per EA (NDC 11523715802), effective Dec 31, 2014.
How has the price of CORICIDIN HBP SOFTGEL changed over time?
Over the history we have for it, the NADAC for CORICIDIN HBP SOFTGEL has risen 4.4%. It has been tracked across 33 weekly CMS publications since May 21, 2014.
What are the highest and lowest recorded NADAC prices for CORICIDIN HBP SOFTGEL?
Since May 21, 2014, the NADAC for CORICIDIN HBP SOFTGEL has ranged from a low of $0.2142 (Jun 18, 2014) to a high of $0.2267 (Dec 31, 2014), with a median of $0.2142 per EA.
Are there cheaper alternatives to CORICIDIN HBP SOFTGEL?
No other NADAC-published product currently shares the active ingredient and strength of CORICIDIN HBP SOFTGEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CORICIDIN HBP SOFTGEL?
CORICIDIN HBP SOFTGEL (NDC 11523715802) is labeled by Bayer HealthCare LLC, and CMS classifies it as a brand product.